Acquirer · Private equity
GrowthCurve Capital
1Undisclosed—0
Image: TailorMedGrowthCurve Capital takes majority control of Israeli medication access startup TailorMed
Israeli business papers valued the deal at about $250 million. Most of TailorMed's venture investors are selling, after the company raised about $60 million since 2016.
Undisclosed$60mStage n/aPrivate equity
Latest in GrowthCurve Capital
All GrowthCurve Capital exitsOpen tracker →
GrowthCurve Capital → TailorMedUndisclosedUndisclosed